Table 1 Patient demographics
Patient # | Gender | Age (Day) | Weight (kg) | PDA | VSD | ASD | Pulmonary hypertension | Others | ASA Grade |
|---|---|---|---|---|---|---|---|---|---|
1 | Female | 79 | 3.7 | Y | Y | Y | Y | Aortic arch hypogenesis | III |
2 | Male | 26 | 2.8 | Y | Y | Y | N | Aortic arch hypogenesis | III |
3 | Male | 50 | 3.8 | Y | Y | Y | Y | Aortic arch hypogenesis | IV |
4 | Male | 141 | 6 | Y | Y | N | Y | III | |
5 | Female | 38 | 2.8 | Y | Y | Y | Y | Aortic arch hypogenesis | IV |
6 | Male | 22 | 3.8 | Y | Y | Y | Y | Respiratory failure | IV |
7 | Female | 74 | 5 | Y | Y | N | Y | III | |
8 | Male | 71 | 4.5 | Y | Y | N | Y | III | |
9 | Male | 41 | 4.5 | Y | Y | N | Y | Patent foramen ovale Mitral and tricuspid insufficiency | IV |
10 | Female | 98 | 4.7 | Y | Y | Y | Y | IV | |
11 | Female | 333 | 6.5 | Y | Y | N | Y | IV | |
12 | Male | 46 | 3.5 | Y | Y | Y | N | IV | |
13 | Male | 47 | 2.8 | Y | Y | N | Y | Patent foramen ovale | III |
14 | Male | 83 | 4.9 | Y | Y | N | Y | III | |
15 | Male | 53 | 4 | Y | Y | N | Y | III | |
16 | Male | 120 | 5.6 | Y | Y | N | N | III | |
17 | Male | 92 | 5.9 | Y | Y | N | N | Patent foramen ovale | III |
18 | Male | 52 | 4.5 | Y | Y | N | Y | Taussig-Bing anomaly | IV |
19 | Male | 12 | 4 | Y | Y | Y | N | III | |
20 | Male | 49 | 4.9 | Y | Y | N | Y | Patent foramen ovale, anomalous coronary origin | IV |
21 | Male | 48 | 4.5 | N | Y | Y | Y | Interrupted Aortic Arch Rh hemolytic disease | IV |